Methods for Hematopoietic Stem Cell Transplantation
AssigneeUniversity of Southern California
InventorsKathleen E. Rodgers, Gere S. diZerega
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treating a subject undergoing hematopoietic stem cell transplantation, methods for increasing a subject's resistance to bacterial or viral infection during and/or following hematopoietic stem cell transplantation, and methods for treating norovirus infection.
Claims25
A method for treating a subject undergoing hematopoietic stem cell transplantation, comprising administering to
- (a) a subject who has completed myelosuppression therapy;
- and/or
- (b) a donor who is donating hematopoietic stem cells to the subject,
- a peptide comprising Asp-Arg-Val-Tyr-Ile-His-Pro (SEQ ID NO:1), or a pharmaceutical salt thereof.
A method for increasing a subject's resistance to bacterial or viral infection during and/or following hematopoietic stem cell transplantation, comprising administering to
- (a) a subject who has completed myelosuppression therapy;
- and/or
- (b) a donor who is donating hematopoietic stem cells to the subject,
- an amount effective of a peptide comprising Asp-Arg-Val-Tyr-Ile-His-Pro (SEQ ID NO:1), or a pharmaceutical salt thereof, to increase the subject's resistance to viral or bacterial infection during and/or following hematopoietic stem cell transplantation.
A method for treating a norovirus infection, comprising administering to a subject in need thereof an amount effective of a peptide comprising Asp-Arg-Val-Tyr-Ile-His-Pro (SEQ ID NO:1), or a pharmaceutical salt thereof, to treat the norovirus infection.
Dependencies are inferred from the claim text.